Literature DB >> 8375434

Pathogenesis of idiopathic parkinsonism.

R J Uitti1, D B Calne.   

Abstract

Idiopathic parkinsonism (Parkinson's disease) makes up the largest diagnostic subgroup of patients with parkinsonism. Various hypotheses exist regarding the pathogenesis of idiopathic parkinsonism: these include genetic predilection aging, environmental factors, oxidative stress, excitotoxicity, autoimmunity, and trauma. We suggest that the pathogenesis of idiopathic parkinsonism is likely to be multifactorial, deriving from environmental factor(s) acting upon a genetically predisposed individual. Because of the compelling evidence indicating common clinical and pathological findings in idiopathic parkinsonism, Alzheimer's disease, and amyotrophic lateral sclerosis, we believe that these conditions result from pathological processes with more similarity than diversity. A primary glutamatergic cell neocortical abnormality provides an attractive unifying explanation which may explain the overlapping abnormalities found in idiopathic parkinsonism, Alzheimer's disease, and amyotrophic lateral sclerosis.

Entities:  

Mesh:

Year:  1993        PMID: 8375434     DOI: 10.1159/000118533

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

1.  CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.

Authors:  David A Loeffler; Lynnae M Smith; Mary P Coffey; Jan O Aasly; Peter A LeWitt
Journal:  J Neural Transm (Vienna)       Date:  2015-11-03       Impact factor: 3.575

2.  Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.

Authors:  W Kuhn; T Müller; R Winkel; S Danielczik; A Gerstner; R Häcker; C Mattern; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Autoimmunity, dendritic cells and relevance for Parkinson's disease.

Authors:  E Koutsilieri; M B Lutz; C Scheller
Journal:  J Neural Transm (Vienna)       Date:  2012-06-15       Impact factor: 3.575

Review 4.  Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.

Authors:  Nataliya Titova; Pablo Martinez-Martin; Elena Katunina; K Ray Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2017-11-07       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.